Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹83 Cr.
Stock P/E
16.7
P/B
1.6
Current Price
₹69
Book Value
₹ 43.4
Face Value
10
52W High
₹158
52W Low
₹ 52.6
Dividend Yield
0%

Renol Polychem Overview

Business

Renol Polychem Ltd. (RNPL) operates in the Chemicals sector, specifically within the Chemicals industry. As a chemical company, its core business likely involves the manufacturing, processing, and distribution of various chemical products. While the specific product portfolio is not detailed, such companies typically produce a range of industrial chemicals, specialty chemicals, or intermediates that serve as raw materials for other industries (e.g., pharmaceuticals, agrochemicals, textiles, paints, plastics, construction). The company generates revenue by selling these chemical products to B2B customers in domestic and potentially international markets.

Revenue Mix

Specific details regarding Renol Polychem Ltd.'s key business segments and their respective revenue contributions are not provided in the given information. Typically, chemical companies might segment their operations by product type (e.g., polymers, specialty chemicals, basic chemicals), application industries, or geographical regions.

Industry

The Indian chemical industry is diverse and highly competitive, characterized by a mix of large integrated players, mid-sized specialty chemical manufacturers, and smaller regional producers. It is also subject to global raw material price fluctuations and increasing environmental regulations. Without specific market share or product differentiation details, Renol Polychem Ltd. likely operates as a participant within a competitive landscape, potentially focusing on specific niches or regional markets. Its positioning relative to peers would depend on its product portfolio, technological capabilities, cost efficiency, and customer relationships.

MOAT

Without specific information, it's challenging to identify strong, durable competitive advantages for Renol Polychem Ltd. Potential sources of competitive advantage in the chemical industry can include:

Cost Leadership: Achieved through economies of scale, efficient manufacturing processes, or access to low-cost raw materials.

Product Specialization/Niche Expertise: Focusing on unique specialty chemicals with high switching costs for customers or proprietary formulations.

Customer Relationships & Supply Chain Integration: Deep integration with key customers, ensuring stable demand.

Regulatory Barriers: Navigating complex environmental and safety regulations more effectively than competitors.

For a company in a competitive segment, establishing a strong moat often requires significant R&D, brand building (less common in B2B chemicals), or proprietary technology.

Growth Drivers

Key factors that could drive Renol Polychem Ltd.'s growth over the next 3-5 years include:

Economic Growth in India: Increased manufacturing output across various end-user industries (e.g., automotive, construction, consumer goods) will drive demand for chemicals.

"Make in India" Initiative: Government focus on boosting domestic manufacturing could lead to higher demand for locally produced chemicals and import substitution opportunities.

Infrastructure Development: Large-scale infrastructure projects require various chemical products (e.g., specialty chemicals for construction materials, paints).

Rising Disposable Incomes: Fuels demand for consumer goods, indirectly increasing the need for chemicals used in their production.

Product Diversification/Innovation: Expanding into new, high-value specialty chemical segments or developing more sustainable products.

Risks

Renol Polychem Ltd. faces several business risks:

Raw Material Price Volatility: Chemical companies are highly exposed to fluctuations in crude oil and other commodity prices, which directly impact production costs and profitability.

Intense Competition: The fragmented Indian chemical market can lead to pricing pressures and margin erosion.

Environmental & Regulatory Risks: Strict and evolving environmental regulations, including waste disposal and emissions standards, can increase compliance costs and operational complexities.

Economic Slowdown: A downturn in end-user industries can significantly reduce demand for chemical products.

Technological Obsolescence: Rapid advancements in chemical processes or new product formulations by competitors could impact market relevance.

Forex Fluctuations: Dependence on imported raw materials or export markets can expose the company to currency exchange rate risks.

Management & Ownership

As an Indian company, Renol Polychem Ltd. is likely promoter-driven, a common ownership structure where the founding family or individuals hold a significant stake and exert considerable influence over management and strategic decisions. The quality of management would typically involve factors like experience, strategic vision, corporate governance practices, and execution capabilities, which would require further investigation beyond the provided information.

Outlook

Renol Polychem Ltd. operates within India's dynamic chemical sector, which benefits from strong long-term macroeconomic tailwinds and government initiatives promoting domestic manufacturing. This provides a fertile ground for demand growth across various chemical product categories. However, the company also navigates a highly competitive environment characterized by raw material price volatility, stringent environmental regulations, and the constant need for technological adaptation. Its success will depend on its ability to manage input costs effectively, differentiate its product offerings, comply with evolving regulations, and expand into high-growth, value-added segments within the broader chemical industry.

Renol Polychem Share Price

Live · NSE · Inception: 2024
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Renol Polychem Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Renol Polychem Profit & Loss

#(Fig in Cr.) Mar 2024 Mar 2025 TTM
Net Sales 6 62
Other Income 0 0
Total Income 7 63
Total Expenditure 4 55
Operating Profit 2 7
Interest 0 1
Depreciation 0 0
Exceptional Income / Expenses 0 0
Profit Before Tax 2 7
Provision for Tax 1 2
Profit After Tax 2 5
Adjustments 0 0
Profit After Adjustments 2 5
Adjusted Earnings Per Share 2.8 9.1

Renol Polychem Balance Sheet

#(Fig in Cr.) Mar 2024 Mar 2025
Shareholder's Funds 9 13
Minority's Interest 0 0
Borrowings 0 0
Other Non-Current Liabilities -0 -0
Total Current Liabilities 7 10
Total Liabilities 15 23
Fixed Assets 0 0
Other Non-Current Assets 0 1
Total Current Assets 15 22
Total Assets 15 23

Renol Polychem Cash Flow

#(Fig in Cr.) Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1
Cash Flow from Operating Activities 1 -1
Cash Flow from Investing Activities 0 -0
Cash Flow from Financing Activities -0 4
Net Cash Inflow / Outflow 1 2
Closing Cash & Cash Equivalent 1 3

Renol Polychem Ratios

# Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.79 9.1
CEPS(Rs) 2.83 9.36
DPS(Rs) 0 0
Book NAV/Share(Rs) 15.83 24.28
Core EBITDA Margin(%) 34.53 11.47
EBIT Margin(%) 35.35 11.66
Pre Tax Margin(%) 33.77 10.7
PAT Margin (%) 23.78 8.02
Cash Profit Margin (%) 24.1 8.25
ROA(%) 9.93 25.75
ROE(%) 17.65 45.37
ROCE(%) 20.23 46.02
Receivable days 350.99 44.43
Inventory Days 391.73 47.43
Payable days 229.12 11.66
PER(x) 0 0
Price/Book(x) 0 0
Dividend Yield(%) 0 0
EV/Net Sales(x) 1.09 0.15
EV/Core EBITDA(x) 3.07 1.28
Net Sales Growth(%) 0 865.98
EBIT Growth(%) 0 218.51
PAT Growth(%) 0 225.76
EPS Growth(%) 0 225.76
Debt/Equity(x) 0.3 0.52
Current Ratio(x) 2.28 2.25
Quick Ratio(x) 1.22 1.32
Interest Cover(x) 22.38 12.14
Total Debt/Mcap(x) 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +933% — — —
Operating Profit CAGR +250% — — —
PAT CAGR +150% — — —
Share Price CAGR -9% — — —
ROE Average +45% +32% +32% +32%
ROCE Average +46% +33% +33% +33%

Renol Polychem Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 51.1 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 48.9 %
# Aug 2025 Sep 2025 Mar 2026
Promoter 69.169.151.1
FII 1.280.680
DII 6.783.630
Public 22.8326.5948.9
Others 000
Total 100100100

Renol Polychem Peer Comparison

Chemicals Edit Columns

Renol Polychem Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Renol Polychem Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 32%
  • Debtor days have improved from 229.12 to 11.66days.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp